Results 31 to 40 of about 25,487 (235)
Background Fluralaner is a novel systemic ectoparasiticide for dogs providing immediate and persistent flea, tick and mite control after a single oral dose.
Feli M. Walther+2 more
doaj +1 more source
Use of Ivermectin as a Potential Chemoprophylaxis for COVID-19 in Egypt: A Randomised Clinical Trial [PDF]
Introduction: The rate of secondary attacks of SARS-COV-2 is high among household close contacts. Social distancing, isolation and infection control measures are important for preventing exposure to infection, but insufficient.
Waheed M Shoumann+7 more
doaj +1 more source
People in the UK are trying to source a parasite drug to use as an unproven treatment for covid-19, reveals Chris Stokel-Walker.
openaire +3 more sources
Uncertainty surrounding projections of the long-term impact of ivermectin treatment on human onchocerciasis. [PDF]
BackgroundRecent studies in Mali, Nigeria, and Senegal have indicated that annual (or biannual) ivermectin distribution may lead to local elimination of human onchocerciasis in certain African foci.
Hugo C Turner+5 more
doaj +1 more source
The gastrointestinal microbiota plays an important role in health of the host animals and the detrimental influence of pharmaceutical treatment on the fecal microbiota receives an increasing concern.
Xinyi Ma+7 more
doaj +1 more source
Domain-based user embedding for competing events on social media [PDF]
Online social networks offer vast opportunities for computational social science, but effective user embedding is crucial for downstream tasks. Traditionally, researchers have used pre-defined network-based user features, such as degree, and centrality measures, and/or content-based features, such as posts and reposts.
arxiv
Complexin in ivermectin resistance in body lice. [PDF]
Ivermectin has emerged as very promising pediculicide, particularly in cases of resistance to commonly used pediculicides. Recently, however, the first field-evolved ivermectin-resistance in lice was reported.
Nadia Amanzougaghene+9 more
doaj +1 more source
Ivermectin Does Not Protect against SARS-CoV-2 Infection in the Syrian Hamster Model
Ivermectin, an FDA-approved antiparasitic drug, has been reported to have in vitro activity against SARS-CoV-2. Increased off-label use of ivermectin for COVID-19 has been reported.
Caroline S. Foo+6 more
doaj +1 more source
Early-life exposure to Ivermectin alters long-term growth and disease susceptibility.
Ivermectin is a broad-spectrum antiparasitic medicine, which is often used as a treatment for parasites or as a prophylaxis. While studies have looked at the long-term effects of Ivermectin on helminths, studies have not considered the long-term impacts ...
Taegan A McMahon+2 more
doaj +1 more source
Ivermectin has New Application in Inhibiting Colorectal Cancer Cell Growth
Colorectal cancer (CRC) is the third most common cancer worldwide and still lacks effective therapy. Ivermectin, an antiparasitic drug, has been shown to possess anti-inflammation, anti-virus, and antitumor properties. However, whether ivermectin affects
Shican Zhou+9 more
doaj +1 more source